Johnson & Johnson has completed its acquisition of Synthes, Inc. and will integrate Synthes with its subsidiary DePuy Orthopaedics to establish the DePuy Synthes Companies of Johnson & Johnson. The deal was sealed with $19.7 billion in cash and stock. “The completion of the Synthes acquisition creates the world’s most innovative and comprehensive orthopaedics business and reflects our long-standing strategy of leadership within attractive health care markets,” said Alex Gorsky, Chief Executive Officer, Johnson & Johnson. “The combination of these two respected leaders — Synthes and DePuy — will enable us to better serve clinicians and patients worldwide, bring new ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.